Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

Instituto Nacional de Cancerologia de Mexico

Mexico
1 Trial

Instituto Nacional de Canciología de México (INCan) is Mexico's federal national cancer institute in Mexico City, operating as a leading oncology specialty hospital and research center. The institute has participated in a clinical trial examining ketamine versus placebo for treating major depression in patients with advanced cancer.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
Mexico
Website
Visit

Sponsored Trials

1
CompletedI, II

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer

Start Date
Compounds
Ketamine, Placebo